Delivery Order SPE2DB24D2012-SPE2DB24FBVRM
Award Date
9/6/24
Potential Completion Date
9/9/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp., a major pharmaceutical distributor. The contract, valued at $2,709.02, is for the delivery of 4,562,376,802 dextroamphetamine tablets, 10 mg, with an ultimate completion date of October 4, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc.,...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide a delivery order for 4,565,519,581 units of dextroamphetamine-amphetamine 20 mg tablets. The $2,205.62 firm-fixed-price contract has an ultimate completion date of August 21, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of 4,567,722,276 units of 10 mg dextroamphetamine tablets. The contract has a ceiling value of $1,238.20 and runs through March 27, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,143.66, is for the delivery of 4,567,018,305 units of dextroamphetamine 5mg tablets. The contract has a firm fixed price and an ultimate completion date of January 24, 2025. This award is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, solicited and awarded by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,274.86 firm-fixed-price delivery order contract covers the provision of 4,566,975,300 units of dextroamphetamine-amphetamine 10 mg tablets. The contract has an ultimate completion date of January 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $1,405.08, is a firm-fixed-price delivery order for the supply of 4,565,526,042 units of the prescription medication dextroamphetamine 20mg, 100 tablets per bottle. The contract has an ultimate completion date of August 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,558,601,061 units of Dextroamphetamine-Amphetamine 10 mg tablets in 100-count bottles. The award, valued at $1,184.59, is a firm fixed-price delivery order contract with a completion date of September 26, 2022. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,776,079 units of the prescription medication dextroamphetamine-amphetamine 20 mg capsules. The $1,126.92 firm fixed-price contract has a completion date of December 23, 2024. It is not designated as a set-aside contract. This award appears to be a delivery order against a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,026.75, is for the delivery of 4,567,426,586 units of 20 mg dextroamphetamine-amphetamine tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 3, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,243.38 firm fixed-price delivery order is for the supply of 4,568,254,602 tablets of the prescription medication dextroamphetamine-amphetamine 10 mg. The contract has an ultimate completion date of May 15, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...